The use of telemedicine to support type 2 diabetes care Pichayes Wiriyapong, Saharat Pongsura, Anjana Fuanchan, Teerapon Dhippayom


  • Pichayes Wiriyapong
  • Saharat Pongsura
  • Anjana Fuanchan
  • Teerapon Dhippayom


Diabetes mellitus, telemedicine, telehealth, e-health


Patients with type two diabetes (T2D) require continual care to control their blood glucose, keep it at normal limits and therefore decrease the risk for long term complications. Telemedicine is one of the most effective approaches for healthcare professionals to deliver diabetes care to enhance accessibility and support patient self-care. There are several types of telemedicine, which can be classified into four groups: telemonitoring, teleconsultation, tele-education, and tele-homecare. The details of providing telemedicine to T2D patients vary widely according to the following features: (1) communication devices, e.g., computers or telephones; (2) communication approach, e.g., one-way reminder communication or direct two-way communication; (3) providers e.g., physicians, nurses, or multidisciplinary teams; (4) frequency of service provision e.g., daily, weekly and monthly. With regard to the evidence from meta-analysis of studies in T2D patients, telemedicine has shown to improve the glycemic control of both hemoglobin A1C and fasting blood glucose and reducing the risk of hypoglycemia compared to usual care, although it had no impact on their quality of life. The findings on economic evaluation differed greatly, which depended on variations in the health care system. Telemedicine can help in terms of controlling diabetes. However, the implementation of telemedicine for T2D patients in Thailand should consider the abilities of the patients in terms of accessing and using related information communication technology, as well as their competency in self-care.


Download data is not yet available.


1. Telemedicine: opportunities and developments in member states: report on the second global survey on eHealth 2009 [Internet]. World Health Organization.
2020. [cited 2020 12 June]; Available from:
2. eHealth strategy, Ministry of Public Health 2017 – 2026 [Internet]. Ministry of Public Health. 2020. 2020 [cited 2020 12 June];Available from:
3. WHA58.28: the fifty-eighth World Health Assembly [Internet]. World Health Organization. 2020. 2020 [cited 2020 12June]; Available from: https://www.who. int/healthacademy/media/WHA58-28-en.pdf?ua=1.
4. Alghamdi SM, Janaudis-Ferreira T, Alhasani R, et al. Acceptance, adherence and dropout rates of individuals with COPD approached in telehealth interventions:
a protocol for systematic review and meta-analysis. BMJ open 2019;9:e026794.
5. Lin Mh, Yuan Wl, Huang Tc, et al. Clinical effectiveness of telemedicine for chronic heart failure: a systematic review and meta-analysis. J Investig Med 2017;65:899-
6. Knox L, Rahman RJ, Beedie C. Quality of life in patients receiving telemedicine enhanced chronic heart failure disease management: A meta-analysis. J Telemed Telecare 2017;23:639-49.
7. Hong Y, Lee SH. Effectiveness of telemonitoring by patient severity and intervention type in chronic obstructive pulmonary disease patients: A systematic review and meta-analysis. Int J Nurs Stud 2019;92:1-15.
8. Aekplakorn W, Stolk RP, Neal B, et al. The prevalence and management of diabetes in Thai adults: the international collaborative study of cardiovascular disease in Asia.
Diabetes Care 2003;26:2758-63.
9. Stratton IM, Adler AI, Neil HAW, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321:405-12.
10. The American Diabetes Association. 5. Facilitating behavior change and wellbeing to improve health outcomes: standards of medical care in diabetes-2020. Diabetes Care 2020;43:S48-S65.
11. Mehrotra A, Jena AB, Busch AB, et al. Utilization of telemedicine among rural Medicare beneficiaries. JAMA 2016;315:2015-6.
12. Lee JY, Wong CP, Tan CSS, et al.Telemonitoring in fasting individuals with Type 2 Diabetes Mellitus during Ramadan: A prospective, randomised controlled
study. Sci Rep 2017;7:10119.
13. Aikens JE, Trivedi R, Aron DC, et al. Integrating support persons into diabetes telemonitoring to improve selfmanagement and medication adherence.J Gen Intern Med 2015;30:319-26.
14. Bell AM, Fonda SJ, Walker MS, et al. Mobile phone-based video messages for diabetes self-care support. J Diabetes Sci Technol 2012;6:310-9.
15. Nagrebetsky A, Larsen M, Craven A, et al. Stepwise self-titration of oral glucoselowering medication using a mobile telephone-based telehealth platform in type 2 diabetes: a feasibility trial in primary care. J Diabetes Sci Technol 2013;7:123-34.
16. Kim HS, Sun C, Yang SJ, et al. Randomized,open-label, parallel group study to evaluate the effect of internet-based glucose management system on subjects with diabetes in China. Telemed J E Health 2016;22:666-74.
17. Rasmussen OW, Lauszus FF, Loekke M. Telemedicine compared with standard care in type 2 diabetes mellitus: a randomized trial in an outpatient clinic. J Telemed Telecare 2016;22:363-8.
18. Noh JH, Cho YJ, Nam HW, et al. Web-based comprehensive information system for self-management of diabetes mellitus. Diabetes Technol Ther 2010;12:333-7.
19. Bowles KH, Dansky KH. Teaching selfmanagement of diabetes via telehomecare.Home Healthc Nurse 2002;20:36-42.
20. Shahid M, Mahar SA, Shaikh S, et al. Mobile phone intervention to improve diabetes care in rural areas of Pakistan: a randomized controlled trial. J Coll Physicians Surg Pak
21. Lemelin A, Godbout A, Pare G, et al. Improved glycemic control through the use of a telehomecare program in patients with diabetes treated with insulin.Diabetes Technol Ther 2020;22:243-8.
22. Ismail K, Winkley K, Rabe-Hesketh S. Systematic review and meta-analysis of randomised controlled trials of psychological interventions to improve glycaemic control in patients with type 2 diabetes. Lancet 2004;363:1589-97.
23. Faruque LI, Wiebe N, Ehteshami-Afshar A, et al. Effect of telemedicine on glycated hemoglobin in diabetes: a systematic review and meta-analysis of randomized
trials. CMAJ 2017;189:E341-4.
24. Zhai YK, Zhu WJ, Cai YL, et al. Clinical-and cost-effectiveness of telemedicine in type 2 diabetes mellitus: a systematic review and meta-analysis. Medicine 2014;93:e312.
25. Tchero H, Kangambega P, Briatte C, et al. Clinical effectiveness of telemedicine in diabetes mellitus: a meta-analysis of 42 randomized controlled trials. Telemed
J E Health 2019;25:569-83.
26. Lee SWH, Chan CKY, Chua SS, et al. Comparative effectiveness of telemedicine strategies on type 2 diabetes management: a systematic review and network metaanalysis. Sci Rep 2017;7:1-11.
27. So CF, Chung JW. Telehealth for diabetes self-management in primary healthcare: a systematic review and meta-analysis. J Telemed Telecare 2018;24:356-64.
28. Marcolino MS, Maia JX, Alkmim MBM, et al. Telemedicine application in the care of diabetes patients: systematic review and meta-analysis. PloS one 2013;8.
29. Lee JY, Lee SWH. Telemedicine cost–effectiveness for diabetes management: A systematic review. Diabetes Technol Ther 2018;20:492-500.
30. The American Diabetes Association. 1. Improving care and promoting health in populations: standards of medical care in diabetes - 2020. Diabetes Care 2020;43:S7-
31. Yingyaun K, Methakanjanasak N. Selfmanagement telehealth innovation for patients with diabetes mellitus type 2 with dyslipidemia. Srinagarind Med J 2016;31:265-71.
32. Raphiphan P. A suitable, efficient, and low cost telecommunication solution for telemedicine for Northeastern region of Thailand remote rural areas. Info Technol
J 2005;1:89-95.






Review Article (บทความวิชาการ)